ADYNOVATE
Antihemophilic Factor (Recombinant) PEGylated · KIT · Takeda Pharmaceuticals Amercia, Inc.
Adynovate is a pegylated recombinant antihemophilic factor used to treat hemophilia A by helping blood clot properly. It is administered by injection as directed by your healthcare provider.
Key Facts
- Brand Name
- ADYNOVATE
- Generic Name
- Antihemophilic Factor (Recombinant) PEGylated
- NDC Code (Product)
0944-4628- Manufacturer
- Takeda Pharmaceuticals Amercia, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125566
- Marketing Start
- 10/25/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is ADYNOVATE used for?
Adynovate is a pegylated recombinant antihemophilic factor used to treat hemophilia A by helping blood clot properly. It is administered by injection as directed by your healthcare provider.
Is ADYNOVATE a controlled substance?
ADYNOVATE is not classified as a controlled substance by the DEA.
What is the generic name for ADYNOVATE?
The generic name for ADYNOVATE is Antihemophilic Factor (Recombinant) PEGylated. There are 5 other brand versions of Antihemophilic Factor (Recombinant) PEGylated.
What is the NDC code for ADYNOVATE ?
The NDC (National Drug Code) for ADYNOVATE is 0944-4628, listed by Takeda Pharmaceuticals Amercia, Inc..